Literature DB >> 17020939

Gene structure and expression of Kaposi's sarcoma-associated herpesvirus ORF56, ORF57, ORF58, and ORF59.

Vladimir Majerciak1, Koji Yamanegi, Zhi-Ming Zheng.   

Abstract

Though similar to those of herpesvirus saimiri and Epstein-Barr virus (EBV), the Kaposi's sarcoma-associated herpesvirus (KSHV) genome features more splice genes and encodes many genes with bicistronic or polycistronic transcripts. In the present study, the gene structure and expression of KSHV ORF56 (primase), ORF57 (MTA), ORF58 (EBV BMRF2 homologue), and ORF59 (DNA polymerase processivity factor) were analyzed in butyrate-activated KSHV(+) JSC-1 cells. ORF56 was expressed at low abundance as a bicistronic ORF56/57 transcript that utilized the same intron, with two alternative branch points, as ORF57 for its RNA splicing. ORF56 was transcribed from two transcription start sites, nucleotides (nt) 78994 (minor) and 79075 (major), but selected the same poly(A) signal as ORF57 for RNA polyadenylation. The majority of ORF56 and ORF57 transcripts were cleaved at nt 83628, although other nearby cleavage sites were selectable. On the opposite strand of the viral genome, colinear ORF58 and ORF59 were transcribed from different transcription start sites, nt 95821 (major) or 95824 (minor) for ORF58 and nt 96790 (minor) or 96794 (major) for ORF59, but shared overlapping poly(A) signals at nt 94492 and 94488. Two cleavage sites, at nt 94477 and nt 94469, could be equally selected for ORF59 polyadenylation, but only the cleavage site at nt 94469 could be selected for ORF58 polyadenylation without disrupting the ORF58 stop codon immediately upstream. ORF58 was expressed in low abundance as a monocistronic transcript, with a long 5' untranslated region (UTR) but a short 3' UTR, whereas ORF59 was expressed in high abundance as a bicistronic transcript, with a short 5' UTR and a long 3' UTR similar to those of polycistronic ORF60 and ORF62. Both ORF56 and ORF59 are targets of ORF57 and were up-regulated significantly in the presence of ORF57, a posttranscriptional regulator.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17020939      PMCID: PMC1676266          DOI: 10.1128/JVI.01394-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors.

Authors:  B Lubyova; P M Pitha
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant.

Authors:  J S Cannon; D Ciufo; A L Hawkins; C A Griffin; M J Borowitz; G S Hayward; R F Ambinder
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Transcriptional analysis of latent and inducible Kaposi's sarcoma-associated herpesvirus transcripts in the K4 to K7 region.

Authors:  Jennifer L Taylor; Heather N Bennett; Beth A Snyder; Patrick S Moore; Yuan Chang
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Genetic organization and hypoxic activation of the Kaposi's sarcoma-associated herpesvirus ORF34-37 gene cluster.

Authors:  Muzammel Haque; Victoria Wang; David A Davis; Zhi-Ming Zheng; Robert Yarchoan
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Origin-independent assembly of Kaposi's sarcoma-associated herpesvirus DNA replication compartments in transient cotransfection assays and association with the ORF-K8 protein and cellular PML.

Authors:  F Y Wu; J H Ahn; D J Alcendor; W J Jang; J Xiao; S D Hayward; G S Hayward
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  The human herpesvirus 8 homolog of Epstein-Barr virus SM protein (KS-SM) is a posttranscriptional activator of gene expression.

Authors:  A K Gupta; V Ruvolo; C Patterson; S Swaminathan
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

7.  Differential regulation of the overlapping Kaposi's sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73) promoters.

Authors:  J Jeong; J Papin; D Dittmer
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

8.  Structural and functional analyses of Kaposi sarcoma-associated herpesvirus ORF57 nuclear localization signals in living cells.

Authors:  Vladimir Majerciak; Koji Yamanegi; Sarah H Nie; Zhi-Ming Zheng
Journal:  J Biol Chem       Date:  2006-07-06       Impact factor: 5.157

9.  Kaposi's sarcoma-associated herpesvirus open reading frame 57 encodes a posttranscriptional regulator with multiple distinct activities.

Authors:  J R Kirshner; D M Lukac; J Chang; D Ganem
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

10.  Characterization of human herpesvirus 8 ORF59 protein (PF-8) and mapping of the processivity and viral DNA polymerase-interacting domains.

Authors:  S R Chan; B Chandran
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

View more
  43 in total

1.  Tiled microarray identification of novel viral transcript structures and distinct transcriptional profiles during two modes of productive murine gammaherpesvirus 68 infection.

Authors:  Benson Yee Hin Cheng; Jizu Zhi; Alexis Santana; Sohail Khan; Eduardo Salinas; J Craig Forrest; Yueting Zheng; Shirin Jaggi; Janet Leatherwood; Laurie T Krug
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

2.  Promoter- and cell-specific transcriptional transactivation by the Kaposi's sarcoma-associated herpesvirus ORF57/Mta protein.

Authors:  Diana Palmeri; Sophia Spadavecchia; Kyla Driscoll Carroll; David M Lukac
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

3.  A comprehensive analysis of recruitment and transactivation potential of K-Rta and K-bZIP during reactivation of Kaposi's sarcoma-associated herpesvirus.

Authors:  Thomas J Ellison; Yoshihiro Izumiya; Chie Izumiya; Paul A Luciw; Hsing-Jien Kung
Journal:  Virology       Date:  2009-03-09       Impact factor: 3.616

4.  Viral microRNA target allows insight into the role of translation in governing microRNA target accessibility.

Authors:  Horng-Ru Lin; Don Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-14       Impact factor: 11.205

5.  Quantitative Analysis of the KSHV Transcriptome Following Primary Infection of Blood and Lymphatic Endothelial Cells.

Authors:  A Gregory Bruce; Serge Barcy; Terri DiMaio; Emilia Gan; H Jacques Garrigues; Michael Lagunoff; Timothy M Rose
Journal:  Pathogens       Date:  2017-03-19

6.  Stability of structured Kaposi's sarcoma-associated herpesvirus ORF57 protein is regulated by protein phosphorylation and homodimerization.

Authors:  Vladimir Majerciak; Natalia Pripuzova; Calvin Chan; Nicholas Temkin; Suzanne I Specht; Zhi-Ming Zheng
Journal:  J Virol       Date:  2015-01-07       Impact factor: 5.103

7.  Kaposi's sarcoma-associated herpesvirus ORF57 is not a bona fide export factor.

Authors:  Guy R Pilkington; Vladimir Majerciak; Jenifer Bear; Hiroaki Uranishi; Zhi-Ming Zheng; Barbara K Felber
Journal:  J Virol       Date:  2012-09-19       Impact factor: 5.103

8.  A Genome-Wide Epstein-Barr Virus Polyadenylation Map and Its Antisense RNA to EBNA.

Authors:  Vladimir Majerciak; Wenjing Yang; Jing Zheng; Jun Zhu; Zhi-Ming Zheng
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

9.  Kaposi's sarcoma-associated herpesvirus ORF57 protein binds and protects a nuclear noncoding RNA from cellular RNA decay pathways.

Authors:  Brooke B Sahin; Denish Patel; Nicholas K Conrad
Journal:  PLoS Pathog       Date:  2010-03-05       Impact factor: 6.823

10.  Interplay between polyadenylate-binding protein 1 and Kaposi's sarcoma-associated herpesvirus ORF57 in accumulation of polyadenylated nuclear RNA, a viral long noncoding RNA.

Authors:  Maria J Massimelli; Vladimir Majerciak; Michael Kruhlak; Zhi-Ming Zheng
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.